Luigi Mangione appeared in court on Friday and confessed to fatally shooting health insurance executive Brian Thompson. He pleaded guilty to two federal charges of stalking the CEO with the intent to kill. Mangione, attired in beige prison clothing, delivered a prepared statement criticizing the U.S. health insurance system in a composed and articulate manner.
During the court session, Thompson’s widow, accompanied by other family members, sat in the front row. Mangione’s admission to the shooting visibly moved her, leading to emotional support from individuals seated beside her.
The guilty plea by Mangione avoids a federal trial in the high-profile case involving the assassination of the 50-year-old UnitedHealthcare CEO. The brazen act, which drew widespread condemnation from the public, symbolized the frustration many Americans feel towards the practices in the health insurance industry.
At 28 years old, Mangione entered his plea without a plea agreement with federal prosecutors. The sentencing, scheduled for December 18, may not necessarily result in leniency as prosecutors are seeking a life sentence, the maximum allowable punishment.
The presiding U.S. District Judge, Margaret Garnett, can take into account Mangione’s guilty plea as a mitigating factor when determining his sentence. Furthermore, the federal plea enabled Mangione’s legal team to file a motion to dismiss separate state murder and weapons charges, citing New York’s double jeopardy law.
In a statement, U.S. Attorney Jamie McDonald emphasized that no accommodations or concessions were made to Mangione by their office. McDonald stressed that no grievance or ideological cause justifies murder, echoing sentiments from Thompson’s family, who viewed the plea as a step towards justice.
Thompson, who previously led the insurance unit of Minnesota-based UnitedHealth Group, was tragically killed outside a hotel during an investor conference on December 4, 2024. The incident, captured in graphic footage, triggered a five-day manhunt leading to Mangione’s arrest in Pennsylvania.
In his courtroom statement, Mangione described encountering obstacles with his insurance following a back injury but did not provide specific details. He admitted to posing as an investor to gain information about the investor conference before crafting a gun component using a 3D printer and traveling to New York with the intention of killing Thompson.
UnitedHealth Group expressed gratitude to law enforcement for apprehending Thompson’s murderer, emphasizing the importance of bringing closure to the case.
Mangione had initially pleaded not guilty to federal murder, weapons, and stalking charges in April 2025, but legal technicalities led to the dismissal of murder and weapons charges in January 2026. The subsequent state case involving terrorism, murder, weapons, and forgery charges is set for trial in September 2025.
As Mangione’s legal team seeks to dismiss the state case under double jeopardy laws, the prosecution remains committed to pursuing justice for Thompson’s family. The complexities of the legal proceedings highlight the challenges faced by both the defence and prosecution in ensuring a fair trial.